Impact of pneumococcal conjugated vaccine on prevention of pneumonia among children from 6 months to 5 years in Zanzibar: population based cross section study

Simple item page
dc.contributor.authorAli, Rahma S.
dc.date.accessioned2019-09-04T06:24:32Z
dc.date.available2019-09-04T06:24:32Z
dc.date.issued2018
dc.descriptionDissertation (MSc Paediatric Nursing)en_US
dc.description.abstractBackground: Pneumonia is responsible for killing at least 1 million children under age of 5, every year: Over 70% of these deaths occur in developing countries. This study intended to determine the impact of pneumococcal conjugated vaccine, on the prevention of pneumonia among children from 6 months to 5 years in Zanzibar. Methods: Study design was a cross-sectional, which employed a quantitative research approach. The study utilized multiple sampling techniques with purposive sampling technique to select the regions and the districts. Additionally, a simple random sampling by lottery was used to select shehia and study participants. A total of 520 respondents were involved in the study, whereby caregivers were responsible on behalf of their children. The study utilized documentary review and questionnaires as the methods for gathering data. The questionnaires contained closed ended questions which were administered to all 520 caregivers. Both descriptive and inferential analysis was done, using SPSS version 20. Results: Majority of participants 48.8% were coming from the urban west, of whom 52.3% were males. Mean age 2.16 (SD= 0.733), whereby vaccinated children were 95.6% and non-vaccinated 4.4%. The prevalence of pneumonia was 32.3%. PCV uptake was 95.6%. Those children who were not vaccinated (AOR 21.696, 95% CI 6.525, 72.137) as compared to vaccinated children. Factors which was observed to contribute to these problem were incomplete dose on time (AOR 34.484, 95% CI 8.965, 13.484), age of children (AOR 0.431, 95% CI 0.243, 0.764), age of caregiver (AOR 4.407, 95% CI 1.581, 12.283) and malnourished children (AOR 1.581, 95% CI 1.069, 2.340). Conclusion: Vaccination with pneumococcal conjugated vaccine significantly, reduced the burden of pneumonia because majority whom were vaccinated and completed all 3 doses within 6 months of age, were free from diseases.en_US
dc.identifier.citationAli, R. S. (2018). Impact of pneumococcal conjugated vaccine on prevention of pneumonia among children from 6 months to 5 years in Zanzibar: population based cross section study. Dodoma: The University of Dodoma.en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12661/1559
dc.language.isoenen_US
dc.publisherThe University of Dodomaen_US
dc.subjectPneumococcal conjugated vaccineen_US
dc.subjectPneumococcal vaccineen_US
dc.subjectPCVen_US
dc.subjectPneumonia preventionen_US
dc.subjectPediatric pneumoniaen_US
dc.subjectPneumococcal vaccineen_US
dc.subjectPneumoniaen_US
dc.subjectZanzibaren_US
dc.subjectVaccinationen_US
dc.subjectChildren vaccinationen_US
dc.titleImpact of pneumococcal conjugated vaccine on prevention of pneumonia among children from 6 months to 5 years in Zanzibar: population based cross section studyen_US
dc.typeDissertationen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Ali, Rahma S..pdf
Size:
2.61 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Master Dissertations